Cue Biopharma, Inc. (CUE) ownership: Top institutional holder: Bleichroeder LP ($1.57M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Bleichroeder LP | 6819164.00 | $1.57M | 2026-03-31 |
| GC Wealth Management RIA, LLC | 4631644.00 | $1.06M | 2026-03-31 |
| VANGUARD GROUP INC | 3014034.00 | $919280.00 | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2457452.00 | $565214.00 | 2026-03-31 |
| Lion Point Capital, LP | 2202854.00 | $506436.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1064690.00 | $244800.00 | 2026-03-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 704297.00 | $215092.00 | 2025-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 543585.00 | $125025.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 |
Back to CUE overview · CUE earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.